Skip to main content
GutCited

Management of irritable bowel syndrome.

A Prior, P J Whorwell
Other Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 1986 4 Zitierungen
PubMed
<\/script>\n
`; }, get iframeSnippet() { const domain = 'gutcited.com'; const params = 'pmid\u003D3011142'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

Study Design

Studientyp
Controlled Clinical Trial
Population
IBS patients
Intervention
Management of irritable bowel syndrome. None
Vergleichsgruppe
None
Primärer Endpunkt
pain
Wirkungsrichtung
Positive
Verzerrungsrisiko
Moderate

Abstract

Few drugs are of proven efficacy in irritable bowel syndrome. Bulking agents probably relieve constipation, spasmolytics may alleviate pain and antidiarrhoeals help control urgency and diarrhoea. With a combination of reassurance and therapeutic intervention up to 75% of patients can be expected to improve. For the 25% who do not, alternative therapies such as stress management, psychotherapy or hypnotherapy may prove effective.

Zusammenfassung

With a combination of reassurance and therapeutic intervention up to 75% of patients can be expected to improve, and alternative therapies such as stress management, psychotherapy or hypnotherapy may prove effective.

Used In Evidence Reviews

Similar Papers